Cargando…
Corticosteroids for Diabetic Macular Edema
Diabetic macular edema (DME) is a chronic condition with a multifactorial pathogenesis. Vascular endothelial growth factor (VEGF) and several inflammatory mediators are upregulated in eyes with DME. VEGF inhibitors and corticosteroids have all been used successfully in the management of DME. Current...
Autores principales: | Chawan-Saad, Jorge, Wu, Max, Wu, Andres, Wu, Lihteh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947754/ https://www.ncbi.nlm.nih.gov/pubmed/31942428 http://dx.doi.org/10.4103/tjo.tjo_68_19 |
Ejemplares similares
-
Macular laser photocoagulation in the management of diabetic macular edema: Still relevant in 2020?
por: Zas, Marcelo, et al.
Publicado: (2020) -
When is macular edema not macular edema? An update on macular telangiectasia type 2
por: Wu, Lihteh
Publicado: (2015) -
Revisiting pars plana vitrectomy in the primary treatment of diabetic macular edema in the era of pharmacological treatment
por: Flikier, Stephanie, et al.
Publicado: (2019) -
Update on corticosteroids for diabetic macular edema
por: Schwartz, Stephen G, et al.
Publicado: (2016) -
Pharmacology of Corticosteroids for Diabetic Macular Edema
por: Whitcup, Scott M., et al.
Publicado: (2018)